profit from every $100 of sales.
$0$100
Schrödinger
$29.53-4.28% today
+71.7% in 1 year
1-year low $11.071-year high $33.39
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Schrödinger sold, what it kept, and what it did with the cash.
Sales went from $181 million in 2022 to $256 million in 2025, with -$103 million of profit last year.
SalesProfit
Schrödinger vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Schrödinger | No profit yet | ||
 GE HealthCare Technologies | 18.0× · Fair price | ||
 BrightSpring Health Services | 74.3× · Very expensive | ||
 Tempus AI | No profit yet | ||
 HealthEquity | 39.8× · Expensive |
AI analysis
An AI analyst reads Schrödinger's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 181 | 217 | 208 | 256 | |
| 101 | 141 | 132 | 143 | |
| -147 | -177 | -209 | -167 | |
| -142 | -172 | -203 | -161 | |
| -149 | 41 | -187 | -103 | |
| -2.10 | 0.54 | -2.57 | -1.41 | |
| 55.8% | 64.9% | 63.6% | 55.7% | |
| -81.1% | -81.9% | -100.8% | -65.2% | |
| -82.4% | 18.8% | -90.2% | -40.4% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 689 | 803 | 823 | 726 |
| Cash | 90 | 155 | 147 | 231 |
| Total debt | 116 | 128 | 118 | 109 |
| Total liabilities | 241 | 254 | 402 | 362 |
| 448 | 549 | 421 | 364 | |
| 71 | 75 | 73 | 73 | |
| -20.6% | -20.7% | -30.7% | -27.9% | |
| -33.3% | 7.4% | -44.4% | -28.4% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -120 | -137 | -157 | 14 | |
| 8 | 13 | 7 | 1 | |
| -128 | -150 | -165 | 12 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 40 | 48 | 50 | 43 |
Valuation
- –
- –
- –
- 2.8×
- 8.7×
- 178.0×
- –
- 0.6%
- -4.7%
- 0.0%
Profitability
- 55.7%
- -65.2%
- -40.4%
- -33.4%
- -34.3%
- -18.5%
- -30.8%
- -16.3%
- -35.5%
- 67.1%
Growth
- +12.2%
- –
- +107.6%
- –
- +1.0%
Financial health
- -0.8×
- 0.34
- 16.9%
- –
- 2.74
- 2.74
- 0.40
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 10%of 963
Bottom 5%of 894
Top 44%of 908
Bottom 42%of 991
What analysts expect
- Average price target
- $18.00
- Range
- $18.00 – $18.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 5, 2026 | -0.81 | -0.56 | −44.6% |
| Feb 25, 2026 | 0.44 | -0.13 | +438.5% |
| Nov 5, 2025 | -0.45 | -0.75 | +40.0% |
| Aug 6, 2025 | -0.59 | -0.83 | +28.9% |
| May 7, 2025 | -0.82 | -0.71 | −15.5% |
| Feb 26, 2025 | -0.55 | -0.35 | −57.1% |
| Nov 12, 2024 | -0.52 | -0.60 | +13.3% |
| Jul 31, 2024 | -0.74 | -0.85 | +12.9% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
31No pass
Benjamin Graham
38No pass
Philip Fisher
38No pass
Peter Lynch
46No pass
Joel Greenblatt
0No pass
Charlie Munger
32No pass
Terry Smith
29No pass
Questions about Schrödinger
Is Schrödinger a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Schrödinger AI analysis
What does Schrödinger do?
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. It is in Medical - Healthcare Information Services.
Does Schrödinger pay a dividend?
No. Schrödinger does not pay a dividend at the moment.
Is Schrödinger stock halal?
Yes. Schrödinger passes our halal screen: its business is permitted and its debt is 5% of its market value, under the 30% limit. How we check
How has Schrödinger stock done over the past year?
Up 71.7% over the past twelve months, to $29.53. It traded between $11.07 and $33.39 and is 11.6% below its high.
Who are Schrödinger's competitors?
The largest listed companies in the same industry are GE HealthCare Technologies, BrightSpring Health Services, Tempus AI and HealthEquity. The peers table on this page compares their profit, growth and price with Schrödinger's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.